Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 8 days ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - about 1 month ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - about 1 month ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 3 months ago Brentuximab Vedotin Shows 37% Reduction in Risk of Death for DLBCL - 3 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 3 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 6 months ago FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients - 6 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 7 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - 9 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 9 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - 10 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - 10 months ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - 12 months ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - 12 months ago
2	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 28 days ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - about 1 month ago New First-Line Option for Pancreatic Cancer Approved - 7 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 9 months ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - 10 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - 10 months ago T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers - 11 months ago Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancer - 11 months ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - 11 months ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 3 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 9 months ago T-DXd Could Be 'Practice-Changing' in HER2-Expressing Gynecologic Cancers - 10 months ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - 10 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 10 months ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic HER2-Positive Solid Tumors - 6 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - 9 months ago Phase 3 Study Supports Pembrolizumab Plus Lenvatinib as Standard of Care in Patients With Advanced Endometrial Cancer Who Received Prior Platinum Therapy - 11 months ago
6	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 6 months ago Utidelone Injectable Granted FDA Orphan Drug Designation for Breast Cancer Brain Metastasis - 6 months ago
7	Kristen Monaco MedPage Today	Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 6 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA OKs Amivantamab as First-Line Lung Cancer Treatment - 7 months ago FDA OKs Maintenance Option for High-Risk Neuroblastoma - 9 months ago Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial - 9 months ago New Oral Drug Approved for Metastatic Colorectal Cancer - 11 months ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - 11 months ago Randomized Trial Backs HIF-2a Inhibition in Advanced RCC - 11 months ago
9	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Accepts BLA for Datopotamab Deruxtecan for the Treatment of NSCLC - 7 months ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - 8 months ago Study: Patients With PD-L1-Positive, High-Risk, ER+/HER2- Breast Cancer Can Achieve Substantial Complete Response Rates With Addition of Nivolumab - 10 months ago New Capivasertib Approval Benefits Patients With Breast Cancer, PIK3CA/AKT1/PTEN Alterations - 10 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - 10 months ago

Journalists covering everolimus